Pistoia Alliance Expands Business Development with Appointment of Carmen Nitsche
Wilmington, DE (PRWEB) September 17, 2014 -- The Pistoia Alliance, a global not for profit organization committed to lowering the barriers to innovation in life sciences R&D through pre-competitive collaboration, has announced the appointment of Carmen Nitsche as Executive Director Business Development North America, as the organization looks to expand its global reach.
Carmen joins the Pistoia Alliance from Accelrys where she was Vice President, Corporate Development. At Accelrys, she managed various life sciences and material sciences M&A activities, and supported existing and prospective partners across the industry spectrum. She also served on the Pistoia Alliance board at this time representing Accelrys. Prior to this, she worked at Symyx Technologies Elsevier MDL and Nalco Chemical Company.
Michael Braxenthaler, President of the Pistoia Alliance said: “Carmen has a wealth of experience in business development, and these skills will be vital as we expand the membership of the Pistoia Alliance. Having served as a board member of Pistoia, Carmen can use her knowledge of the Alliance and its goals, combined with her extensive business development experience, to increase membership of the Alliance.”
Carmen Nitsche added: “The Pistoia Alliance has done an excellent job in developing projects which make a difference to the life sciences industry. Projects such as HELM and CSCS have made researchers lives much easier, and I look forward to highlighting these and other planned projects to prospective members and partners.”
Carmen’s appointment follows a number of changes at the Pistoia Alliance, which has seen John Wise, formerly Executive Director, become Executive Director, Business Development, Europe, and Richard Holland become Executive Director, Operations.
About the Pistoia Alliance
The Pistoia Alliance is a not-for-profit, cross-company, members’ organization, formally incorporated in the State of Delaware. It is committed to lowering the barriers to innovation in life sciences R&D by improving the interoperability of R&D business processes through precompetitive collaboration. It draws its membership widely from life science R&D including Pharma R&D, commercial information providers, technology companies and publicly-funded research institutes. The Pistoia Alliance creates a virtual, open-innovation community by bringing together the key stakeholders to identify the root causes that lead to life science R&D inefficiencies and then develops best practices, technology implementations and standards to overcome these common obstacles. For further information about the Pistoia Alliance please visit our website, http://www.pistoiaalliance.org/.
John Wise, The Pistoia Alliance, http://www.pistoiaalliance.org/, +44 7768173518, [email protected]
Share this article